Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $629.8000 (-1.18%) ($628.3400 - $644.3150) on Thu. Jul. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 55 | Latest Price | $629.8000(-1.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(40%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.28% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $630.11 | 5 Day Moving Average | $641.63(-1.84%) | 10 Day Moving Average | $635.25(-0.86%) | 20 Day Moving Average | $630.11(-0.05%) | To recent high | -4.3% | To recent low | 22.1% | Market Cap | $66.777b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |